Pharmaceuticals(39)

  • Natural Human Antibodies to Treat Cancer (No. T4-2152)

    Ovarian cancer is the fifth leading cause of cancer-related death in women. Due to a lack of early detection methods, it is often diagnosed at a late stage, resulting in negligible changes to cure. ... Read more
    Full Professor Irit Sagi

    Irit Sagi

    Faculty of Biology

    17825
  • Treating myeloid malignancies with Rock inhibitors (No. T4-2147)

    Acute myeloid leukemia  (AML) incidents increases with age and mortality exceeds 90% when it is diagnosed after the age of 65. Specific mutations were shown to exist in pre-leukemic subjects years before the disease breaks. ... Read more
    Senior Scientist Liran Shlush

    Liran Shlush

    Faculty of Biology

    18409
  • Diagnosis and Treatment of Breast Cancer based on Extracellular Vesicles (No. T4-2145)

    Early detection of breast cancer (BC) and monitoring its progression, treatment response, and recurrence are crucial for survival. ... Read more
    Prof Sima Lev

    Sima Lev

    Faculty of Biology

    16676
  • Design of a Multivalent mRNA Vaccine to Protect Against Multiple Variants (No. T4-2136)

    The constant emergence of new variants threatens the success of the mRNA vaccines developed against SARS-CoV-2. Therefore, there is an urgent need to develop a vaccine that will provide immunity against multiple variants – both existing and potential. Prof. ... Read more
    Prof Yitzhak Pilpel

    Yitzhak Pilpel

    Faculty of Biochemistry

    14762
  • Novel Combination Therapy For Improved Management of Depression (No. T4-2129)

    Psychiatric disorders, especially major depressive disorder (MDD), are leading causes of disability and premature death across the globe, with patients showing a heightened risk of self-harm and suicidal ideation. Prof. ... Read more
    Full Professor Alon Chen

    Alon Chen

    Faculty of Biology

    6097
  • Modulating Weight Gain and Loss by Understanding the Mechanism of Smoking Related Weight Changes (No. T4-2078)

    Of the approximately 30 million adult smokers in the U.S, more than half report attempting to quit smoking every year. However, smoking cessation-associated weight gain (SCWG) constitutes a major obstacle to smoking withdrawal. ... Read more
    Associate Professor Eran Elinav

    Eran Elinav

    Faculty of Biology

    17357
  • Treatment for Ewing Sarcoma Using ETS Proteins (No. T4-2068)

    Ewing sarcoma (ES) is a common bone malignancy in children and young adolescents which is usually treated by systemic chemotherapy. In about 25% of the cases, cancer has already spread to other parts of the body at the time of diagnosis. ... Read more
    Extension Service Yosef Yarden

    Yosef Yarden

    Faculty of Biology

    6154
  • Inhibitory Proteins for 20S Proteasome Regulation as Cancer Treatment (No. T4-2065)

    Proteasomal protein degradation is crucial in maintaining cellular integrity and in regulating key cellular processes including cell cycle, proliferation and cell death. ... Read more
    Associate Professor Michal Sharon

    Michal Sharon

    Faculty of Biochemistry

    6139
  • Increasing Immunotherapy Efficacy of Anti PD-L1 (No. T4-2059)

    Immunotherapy has revolutionized cancer treatment by activating the immune system to attack tumor cells. However, notable limitations remain, including differential responses between individuals and cancer types. Dr. ... Read more
    Prof Rony Dahan

    Rony Dahan

    Faculty of Biology

    17039
  • Peptides for Treating Alzheimer's Disease (No. T4-2057)

    Alzheimer's Disease (AD) is an age-associated neurodegenerative disorder characterized clinically by a decline in cognitive function. It is the most common type of dementia, with 5.8 million Americans living with AS in 2020. ... Read more
    Full Professor Ruth Arnon

    Ruth Arnon

    Faculty of Biology

    6160

Pages

Subscribe to Pharmaceuticals